Oxygen News and Research

RSS

Treatment with xenon gas after head injury reduces extent of brain damage

Treatment with xenon gas after a head injury reduces the extent of brain damage, according to a study in mice.

9 Sep 2014

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago.

9 Sep 2014

UT Southwestern Medical Center's multi-disciplinary wound care efforts

UT Southwestern Medical Center's multi-disciplinary wound care efforts have converged in a new, state-of-the-art clinic.

9 Sep 2014

Extreme environment medicine: an interview with Dr Kevin Fong, University College London

The understanding of how long-duration space flight affects the human body has come on quite considerably in recent years, and in large part, we owe that to programs of research that have taken place aboard the International Space Station and the Mir Space Station.

8 Sep 2014

Researchers measure stiffness of membrane surrounding red blood cells over time

It may look like fresh blood and flow like fresh blood, but the longer blood is stored, the less it can carry oxygen into the tiny microcapillaries of the body, says a new study from University of Illinois researchers.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

5 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

4 Sep 2014

Football players are found to be carriers of sickle cell trait later in life

From 2000 to 2014, nine collegiate football players unexpectedly collapsed and died during training. The cause? Muscle breakdown leading to organ failure.

4 Sep 2014

Project aims at establishing central biobank for development of new drugs

Human stem cells allow scientists to assess how patients are likely to respond to new drugs and to examine how illnesses come about.

4 Sep 2014

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.

3 Sep 2014

Inhaled nitric oxide given to heart attack patients may improve recovery

Inhaled nitric oxide, delivered to heart attack patients before and during treatment with percutaneous coronary intervention (PCI) did not reduce the extent of damaged tissue (infarct), but may have improved recovery, according to Hot Line results presented today at ESC Congress 2014.

2 Sep 2014

Study suggests that energy drinks can cause heart problems

Energy drinks can cause heart problems according to research presented at ESC Congress 2014 today by Professor Milou-Daniel Drici from France.

1 Sep 2014

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Heart failure patients with iron deficiency can experience significant and sustainable improvements in functional capacity and quality of life as well as reduced risk of hospital admission for worsening heart failure by receiving just one to two intravenous doses of an iron supplement, according to the results of a study presented today at ESC Congress 2014.

30 Aug 2014

Comprehensive fitness and nutrition regimens may prevent bone and muscle deterioration

Being physically active may significantly improve musculoskeletal and overall health, and minimize or delay the effects of aging, according to a review of the latest research on senior athletes (ages 65 and up) appearing in the September issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

30 Aug 2014

Internal production of hydrogen peroxide can lead cells to exit cell cycle and become senescent

What happens inside cells when they detect the activation of a cancer-inducing gene? Sometimes, cells are able to signal internally to stop the cell cycle. Such cells are able to enter, at least for a time, a protective non-growth state.

30 Aug 2014

Climate change threatens survival of Devils Hole pupfish

Climate change is hurting reproduction of the endangered Devils Hole pupfish, threatening the survival of this rare species that has numbered as few as 35 individuals, new research by the University of Nevada, Reno and Desert Research Institute shows.

29 Aug 2014

Vasopressin more effective for cardiopulmonary resuscitation

Epinephrine has been shown to be a first-choice drug for cardiopulmonary resuscitation. Nevertheless, its β-adrenergic effect probably increases myocardial oxygen consumption and leads to severe cardiac and cerebral injuries; moreover, epinephrine does not elevate long-term survival rates.

29 Aug 2014

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study from Johns Hopkins suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body.

28 Aug 2014

Oxygen News and Research

Treatment with xenon gas after head injury reduces extent of brain damage

New potential therapeutic targets for treatment of pulmonary arterial hypertension

UT Southwestern Medical Center's multi-disciplinary wound care efforts

Extreme environment medicine: an interview with Dr Kevin Fong, University College London

Researchers measure stiffness of membrane surrounding red blood cells over time

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Keytruda drug gets FDA approval for treatment of advanced melanoma

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Sepsis patients more likely to survive when treated at hospital with higher volume of cases

Football players are found to be carriers of sickle cell trait later in life

Project aims at establishing central biobank for development of new drugs

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

Inhaled nitric oxide given to heart attack patients may improve recovery

Study suggests that energy drinks can cause heart problems

Intravenous iron supplement can improve quality of life for iron deficient heart failure patients

Comprehensive fitness and nutrition regimens may prevent bone and muscle deterioration

Internal production of hydrogen peroxide can lead cells to exit cell cycle and become senescent

Climate change threatens survival of Devils Hole pupfish

Vasopressin more effective for cardiopulmonary resuscitation

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC